Search results
Author(s):
George D Katritsis
,
Demosthenes G Katritsis
Added:
3 years ago
Implantable cardiac devices, such as pacemakers, are used to treat a number of heart conditions, especially those related to the electrical conduction system. Cardiac pacemakers are a well-established and effective therapy, and have been in use for more than 50 years.
The first pacemaker was implanted in a patient in October 1958 by Åke Senning in Stockholm, in cooperation with engineer Rune…
View more
Author(s):
Eun-Jeong Kim
,
Giovanni Davogustto
,
William G Stevenson
,
et al
Added:
3 years ago
Myocardial scars from infarction or replacement fibrosis in non-ischaemic cardiomyopathies are the common substrate for sustained monomorphic ventricular tachycardia (VT).1,2 In selected patients at high risk of ventricular arrhythmias, placement of an implantable cardioverter-defibrillator (ICD) is effective for prevention of sudden cardiac death.2 Although ICDs are effective in terminating VT…
View more
Body Surface Electrocardiographic Mapping for Non-invasive Identification of Arrhythmic Sources
Author(s):
Ashok J Shah
,
Meleze Hocini
,
Patrizio Pascale
,
et al
Added:
3 years ago
Article
Author(s):
Jorge E Romero
,
Dan L Li
,
Ricardo Avendano
,
et al
Added:
3 years ago
Brugada syndrome (BrS), one of the most common causes of sudden cardiac death (SCD) in normal structural heart individuals, is a young entity in modern medicine. BrS was first characterised in 1992 by Brugada et al. as a distinct syndrome with “right bundle branch block, persistent ST elevation in precordial leads V1 to V2–3 and sudden cardiac death”.1 The true prevalence of BrS is not clearly…
View more
Hybrid Ablation – AF and Beyond
Video Series
Drivers of Atrial Fibrillation
Author(s):
Ian Mann
,
Belinda Sandler
,
Nick WF Linton
,
et al
Added:
3 years ago
Article
Author(s):
Simon Ermakov
,
Melvin Scheinman
Added:
3 years ago
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterised by progressive replacement of the ventricular myocardium by fibrofatty tissue.1 Patients with the disease are predisposed to ventricular arrhythmias, heart failure and sudden cardiac death.
Pathophysiology
ARVC has a strong genetic basis with most disease variants displaying an autosomal dominant…
View more
Author(s):
Dhanunjaya Lakkireddy
Added:
2 years ago
In this interview, Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Overland Park, KS, US) discusses the outcomes of the multicenter Susruta-IST Registry, which aimed to report upon the outcomes of sinus node sparing surgical thoracoscopic hybrid ablation (SUSRUTA) for inappropriate sinus tachycardia (IST).
Questions:
1. Please summarise the aim, study design and endpoints?
2. What…
View more
Author(s):
Jorge E Romero
,
Ricardo Avendano
,
Michael Grushko
,
et al
Added:
3 years ago
Oesophageal injury prevention has become a major concern in the field of electrophysiology since the first case of atrio–oesophageal fistula was reported as a complication of endocardial surgical radiofrequency ablation (RFA),1 with Scanavacca et al. and Pappone et al. subsequently reporting this complication in patients who underwent percutaneous pulmonary vein isolation (PVI) for AF.2,3 It is…
View more
HRS 2020: CONVERGE Trial
Author(s):
David DeLurgio
Added:
3 years ago
Video